How Rendle was paid
$13.3M in total for fiscal Year 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Incentive | Pension | Other | Total |
|---|---|---|---|---|---|---|---|
| Linda RendleChair and Chief Executive Officer (CEO) | $1,307,692 | — | $9,754,753 | $1,696,000 | — | $574,587 | $13,333,032 |
| Luc BelletEVP and Chief Financial Officer (CFO) | $514,776 | — | $1,599,673 | $362,301 | — | $145,546 | $2,622,295 |
| Eric ReynoldsEVP and Chief Operating & Strategy Officer | $806,923 | — | $2,999,828 | $684,600 | $418 | $271,097 | $4,762,866 |
| Nina BartonEVP and Group President–Care & Connection | $646,154 | $840,728 | $7,998,301 | $475,003 | — | $110,676 | $10,070,862 |
| Chris HyderEVP and Group President–Health & Hygiene | $669,231 | — | $2,999,203 | $486,000 | — | $211,934 | $4,366,368 |
| Kevin JacobsenFormer EVP and Chief Financial Officer | $650,192 | — | $2,799,730 | $513,383 | $6,097 | $276,939 | $4,246,342 |
What changed and why
- 133%133%: Performance share units vesting in 2024 paid out at 133% after two years exceeded maximum performance levels.
- 80%80%: The fiscal 2025 short-term incentive Company multiplier reflected below-target sales, strong gross margin, and solid net earnings.
- 90%90% of target CEO compensation was at risk, compared with 85% on average for other named executives.
- $841KNina Barton received an $840,728 one-time cash sign-on payment, repayable after qualifying departures within two years.
- 50%Annual incentives used net sales, net earnings, and gross margin, weighted 50%, 30%, and 20%, respectively.
Other Clorox proxy statements
- 2026 proxy statement
Linda Rendle paid $14M (+5% on the year), pay ratio 168:1.
Filed Oct 07, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.